Abstract
Background
IL-12/23-interferon-γ circuit enhances reactive oxygen species (ROS) synthesis in macrophage to attack intracellular pathogens such as mycobacteria and salmonella. Defective ROS in patients with chronic granulomatous disease (CGD) have increased susceptibility to these pathogens. However, patients with defective IL-12/23-interferon-γ circuit rather than CGD are not recognized in Taiwan, endemic for tuberculosis and salmonella.
Aim
The purpose of this study was to identify Taiwanese patients with defective IL-12/23-IFN-γ circuit.
Patients and Methods
In a long-term molecular study of primary immunodeficiency diseases (PIDD), the tentative CGD patients presenting with Bacille Calmette–Guerin (BCG)-induced infection, refractory atypical mycobacterial cutaneous granuloma and osteomyelitis, recurrent salmonella sepsis, and pneumatocele were studied for the IL-12/23-IFN-γ circuit. ROS was first measured to exclude CGD. Candidate genes of IL12RB1, IFNRG1, IL12p40, IFNRG2, signal transducer and activator of transcription-1, and NF-κB essential modulator and their encoding protein expressions were analyzed.
Results
Of the 175 Taiwanese PIDD patients during a 28-year period, three patients from two unrelated families were identified with the hotspot INFRG1 deletion mutation (818del4) and had CGD features, presenting as cutaneous granuloma, and multiple osteomyelitis infected by non-tuberculosis mycobacteria, Mycobacteria avium complex and Mycobacterium scrofulaceum. Another with mis-sense IL12RB1 mutation (Arg211Pro) was noted as recurrent Salmonella enteritidis D sepsis and pneumatocele.
Conclusion
Patients with defective IL-12/23-IFN-γ circuit may resemble or overlap CGD manifestations of refractory cutaneous atypical mycobacterial granuloma and salmonella pneumatocele.
Similar content being viewed by others
Abbreviations
- BCG:
-
Bacille Calmette–Guerin
- CMC:
-
chronic mucocutaneous candidiasis
- PBMCs:
-
peripheral blood mononuclear cells
- PIDD:
-
primary immunodeficiency diseases
- ROS:
-
reactive oxygen species
- SCID:
-
severe combined immunodeficiency
References
Abbas AK, Lichtman AH. Effector mechanisms of cell-mediated immunity. In: Abbas AK, Lichtman AH, editors. Cellular and molecular immunology. 5th ed. PA: Saunders; 2003. p. 298–317.
Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002;20:581–620. doi:10.1146/annurev.immunol.20.081501.125851.
Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000;11:321–33. doi:10.1016/S1359-6101(00)00010-1.
Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004;364:2113–21. doi:10.1016/S0140-6736(04)17552-1.
Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998;101:2364–9. doi:10.1172/JCI2901.
Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajjar S, Feinberg J, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002;70:336–48. doi:10.1086/338625.
Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med 2003;197:527–35. doi:10.1084/jem.20021769.
Dupuis S, Dargemont C, Fieschi C, Thomassin N, Rosenzweig S, Harris J, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001;293:300–3. doi:10.1126/science.1061154.
Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, Puel A, et al. X-linked susceptibility to mycobacteria is caused by mutations in the NEMO leucine zipper domain that impair CD40-dependent IL-12 production. J Exp Med 2006;203:1745–59. doi:10.1084/jem.20060085.
Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006;18:347–61. doi:10.1016/j.smim.2006.07.010.
Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698–702. doi:10.1001/jama.271.9.698.
Lee WI, Jaing TH, Hsieh MY, Kuo ML, Lin SJ, Huang JL. , infections, treatments and molecular analysis in a large cohort of patients with primary immunodeficiency diseases (PIDs) in Taiwan. J Clin Immunol 2006;26:274–83. doi:10.1007/s10875-006-9013-7.
Liang FC, Wei YC, Jiang TH, Hsieh MY, Wen YC, Chiou YS, et al. Current classification and status of primary immunodeficiency diseases in Taiwan. Acta Paediatr Taiwan 2008;49:3–8.
Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, et al. Bacille Calmette–Guerin vaccine-induced disease in HIV-infected and HIV infected children. Clin Infect Dis 2006;42:548–58. doi:10.1086/499953.
Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 2005;105:1881–90. doi:10.1182/blood-2003-12-4420.
Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Fondanèche MC, Dupuis S, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999;21:370–8. doi:10.1038/7701.
Yu HR, Chen RF, Hong KC, Bong CN, Lee WI, Kuo HC, et al. IL-12-independent Th1 polarization in human mononuclear cells infected with varicella-zoster virus. Eur J Immunol 2005;35:3664–72. doi:10.1002/eji.200526258.
Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet 1995;346:581. doi:10.1016/S0140-6736(95)91421-8.
Talbot EA, Perkins MD, Silva SF, Frothingham R. Disseminated bacilli Calmette–Guerin disease after vaccination: case report and review. Clin Infect Dis 1997;24:1139–46. doi:10.1086/513642.
Reichenbach J, Rosenzweig S, Doffinger R, Dupuis S, Holland SM, Casanova JL. Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2001;1:503–11. doi:10.1097/00130832-200112000-00003.
Niehues T, Reichenbach J, Neubert J, Gudowius S, Puel A, Horneff G, et al. Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J Allergy Clin Immunol 2004;114:1456–62. doi:10.1016/j.jaci.2004.08.047.
Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, Chapgier A, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol 2007;120:32–8. doi:10.1016/j.jaci.2007.04.034.
Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000;79:155–69. doi:10.1097/00005792-200005000-00003.
Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006;25:745–55. doi:10.1016/j.immuni.2006.09.009.
Babior BM. NADPH oxidase. Curr Opin Immunol 2004;16:42–7. doi:10.1016/j.coi.2003.12.001.
Lee PP, Chan KW, Jiang L, Chen T, Li C, Lee TL, et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living a region endemic for tuberculosis. Pediatr Infect Dis J 2008;27:224–30.
Roos D, Kijpers TW, Curnutte JT. Chronic granulomatous disease. In: Ochs HD, Smith CIE, Puck JM, editors. Primary immunodeficiency diseases. 2nd ed. NY: Oxford; 2007. p. 525–49.
Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, et al. International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee: International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007;120:776–94. doi:10.1016/j.jaci.2007.08.053.
Ozen M, Ceyhan M, Sanal O, Bayraktar M, Mesci L. Recurrent Salmonella bacteremia in interleukin-12 receptor beta1 deficiency. J Trop Pediatr 2006;52:296–8. doi:10.1093/tropej/fml001.
Roesler J, Horwitz ME, Picard C, Bordigoni P, Davies G, Koscielniak E, et al. Hematopoietic stem cell transplantation for complete IFNgamma receptor 1 deficiency: a multi-institutional survey. J Pediatr 2004;145:806–12. doi:10.1016/j.jpeds.2004.08.021.
Horwitz ME, Uzel G, Linton GF, Miller JA, Brown MR, Malech HL, et al. Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferongamma receptor-1 deficiency. Blood 2003;102:2692–4. doi:10.1182/blood-2003-04-1268.
Lee PP, Jiang LP, Wang XC, Chan KW, Tu WW, Lau YL. Severe mycobacterial infections in two pairs of Chinese siblings with interleukin-12 receptor beta1 deficiency. Eur J Pediatr 2008;167:231–2. doi:10.1007/s00431-007-0430-2.
Zou CC, Zhao ZY. Clinical and molecular analysis of NF-kappa B essential modulator in Chinese incontinentia pigmenti patients. Int J Dermatol 2007;46:1017–22. doi:10.1111/j.1365-4632.2007.03365.x.
Acknowledgments
The authors wish to thank all of the patients and their families for their kind cooperation, as well as their physicians for the referrals. They also thank Yi-Chen Wang, Hsiu-Li Chou, and Hsiu-Shan Hsiao for their technical assistance. This study was supported by Chang-Gung Medical Research Progress Grant CMRPG 450061 and National Science Council Grants NSC96-2314-B-182A-053-MY2 and NMRPG466062.
Conflict of interest statement
All of the authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, WI., Huang, JL., Lin, TY. et al. Chinese Patients with Defective IL-12/23-Interferon-γ Circuit in Taiwan: Partial Dominant Interferon-γ Receptor 1 Mutation Presenting as Cutaneous Granuloma and IL-12 Receptor β1 Mutation as Pneumatocele. J Clin Immunol 29, 238–245 (2009). https://doi.org/10.1007/s10875-008-9253-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-008-9253-9